Clinical Emerging Investigator
The Novo Nordisk Foundation’s Clinical Emerging Investigator grant supports early-career clinical researchers who are establishing an independent research group, with grants of DKK 8–12.5 million over five years. This guide covers suitable research areas, eligibility and readiness checks, what assessment panels typically value and how to shape a competitive application.
The published deadline has passed. Check the official page in case it has been extended, or browse the open listings.
Key dates
- Application deadline
- 20 January 2027
- Details last checked
- 10 November 2026
About the call
- Funder
- Novo Nordisk Foundation
- Country
- Denmark
- Scheme type
- Fellowship
- Funding
- DKK 8–12.5 million per grant over five years (up to DKK 50 million in total)
- Eligibility
- Early-career clinical researchers establishing an independent research group; up to four grants will be awarded.
- Scope
- Medicine and clinical research
Topics consistent with the call
- Patient-oriented clinical studies addressing important unmet medical needs
- Translational research linking laboratory findings to clinical diagnosis or treatment
- Clinical cohorts and registries used to investigate disease mechanisms
- Investigator-initiated trials testing new or repurposed interventions
- Biomarker discovery and validation for prognosis or treatment response
- Precision medicine approaches for stratifying patients in clinical practice
Based on the published scope; the official page sets out the full themes and requirements.
Is your work a fit? Check before you apply
- Confirm that your career stage and clinical background meet the eligibility criteria in the call documents.
- Check that you are ready to lead an independent research group with a clear five-year plan.
- Ensure the host institution and clinical environment can support the proposed research.
- Verify that the requested budget falls within the DKK 8–12.5 million range stated for the scheme.
- Prepare a complete, institutionally approved application well before the 20 January 2027 deadline.
Why This Funding Call Matters
Clinical researchers often find the move from postdoctoral or junior clinical work to independent group leadership the hardest step in their careers, because protected research time and stable funding are scarce alongside clinical duties. A five-year grant of this scale allows an emerging investigator to recruit a team, build a coherent research programme and generate evidence that can change patient care. With only up to four grants available, the scheme rewards applicants who can present a focused, ambitious and realistic programme rooted in clinical questions.
Who Should Apply
Academic backgrounds
- Clinical medicine and medical specialties
- Translational medicine
- Clinical epidemiology
- Surgery and perioperative medicine
- Clinical pharmacology
Institutions and sectors
- University hospitals
- Universities with medical faculties
- Regional hospital research units
- Clinical research centres
What Reviewers Typically Value
- A clearly defined clinical problem whose solution would benefit patients.
- A research programme that is ambitious yet feasible within five years.
- Evidence that the applicant is emerging as an independent research leader.
- Methods that integrate clinical data, patient samples or trials with rigorous analysis.
Ideas You Could Develop
Your Plan to the Deadline
A suggested schedule working back from 20 January 2027. Adjust it to the stage your work has reached.
By 25 Nov 2026
Read the call documents; confirm eligibility, budget limits, assessment criteria and institutional requirements.
By 9 Dec 2026
Agree the research question, aims, team and partners; contact your research office.
By 23 Dec 2026
Draft the case for support, methods, impact and budget.
By 6 Jan 2027
Obtain internal review, letters of support and institutional sign-off.
By 15 Jan 2027
Final checks against the funder’s guidance and formatting rules.
By 20 Jan 2027
Submit through the funder’s system before the deadline.
What you gain
- Funding for the research, team and resources it needs.
- Recognition from a competitive, peer-reviewed process.
- Reviewer feedback that strengthens future applications.
- A track record for larger grants and fellowships.
What happens after you apply
- Eligibility check: the funder confirms the application meets the call rules.
- Peer review: external reviewers assess the proposal against the published criteria.
- Panel: a committee ranks proposals; some schemes include an interview.
- Decision: outcomes are released on the funder’s timetable.
- Award: successful applicants agree terms and reporting requirements before starting.
What the Funder Are Looking For
The scheme looks for early-career clinical researchers who are ready to establish an independent research group and lead a sustained programme of clinically relevant research. Strong applications typically show a convincing clinical question, a credible plan for building a team over five years, a supportive host environment and a track record that signals growing independence. Applicants should confirm detailed eligibility, assessment criteria and budget rules in the Novo Nordisk Foundation call documents.
Expert help
How Pubrica Can Help
Pubrica’s subject specialists can help you prepare a competitive proposal, planned back from the deadline. You remain the author of your work.
FAQs
Questions Researchers Ask
The next published deadline is 20 January 2027. Dates can change, so confirm them on the official page before you plan your work.
The scheme is aimed at clinical researchers, so clinical work alongside research is likely to be expected, but the rules on protected research time and salary may be specific. Check the call documents on the Novo Nordisk Foundation website and contact the Foundation if your situation is unusual.
Early-career clinical researchers establishing an independent research group; up to four grants will be awarded. Confirm the full eligibility rules in the call documents.
Yes. Pubrica’s specialists can review, write, edit and format your proposal. You remain the author and the person responsible for the submission.
Sources
- Novo Nordisk Foundation. (2026). Clinical Emerging Investigator. Retrieved 10 November 2026, from https://novonordiskfonden.dk/en/grant/clinical-emerging-investigator/
How to cite this page
Pubrica Insights. (2026). Clinical Emerging Investigator. Pubrica. https://pubrica.com/insights/calls-and-conferences/clinical-emerging-investigator/
Pubrica Insights. “Clinical Emerging Investigator.” Pubrica, 2026, https://pubrica.com/insights/calls-and-conferences/clinical-emerging-investigator/.
Pubrica Insights (2026) Clinical Emerging Investigator. Pubrica. Available at: https://pubrica.com/insights/calls-and-conferences/clinical-emerging-investigator/ (Accessed: 10 November 2026).
Pubrica Insights. Clinical Emerging Investigator [Internet]. Pubrica; 2026 [cited 2026 Nov 10]. Available from: https://pubrica.com/insights/calls-and-conferences/clinical-emerging-investigator/
Funding call